explore -WSS

explore

author：leisure time 2025-09-27 22:18:11 - browse：75

STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024 — From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

“We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： 10 million people disenrolled from Medicaid over past six months

focus

WSS

New brain studies show LSD's effects on the brain in full color

Copay coupons to count toward deductibles, after Biden court move

The new shift in health care is toward less care

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Removing probiotics from the NICU could threaten preemies' health

Test for long Covid? Researchers find new clue in blood samples

hotspot

explore

entertainment

Hepatitis C has a cure — but many Americans still lack access to it

Independent physicians launch a new lobbying group

In age of alternative facts, a scholarly course on calling out crap

Diversify hospital leadership teams to protect BIPOC patient health

How one medical school became remarkably diverse

Excited delirium, Elijah McClain, and emergency physicians

23andMe had bad news about my health. I wish a person had delivered it

Abortion clinic in Cancun will cater to Americans

Malaria cases in Florida and Texas: Here’s what you need to know

Medicare Advantage today, explained in one chart

entertainment

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Biotech venture capitalists face new demands from investors

10 million people disenrolled from Medicaid over past six months

Removing probiotics from the NICU could threaten preemies' health

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Sanofi CEO defends move to abandon profit guidance, boost research

focus

leisure time

focus

hotspot